The Patent Finder

Galapagos Sasu

Also on record
Records under this name other than patents Galapagos Sasu holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Galapagos Sasu

PatentTitleStatus Expires Confidence
US 9,415,037Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
conveyed to Galapagos N.V. - now held by Alfasigma S.P.A.
In force
 · High confidence
In forceHigh confidence
US 10,206,907Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
conveyed to Galapagos N.V. - now held by Alfasigma S.P.A.
In force
 · High confidence
In forceHigh confidence
US 8,853,240Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
now held by Alfasigma S.P.A.
In force
 · High confidence
In forceHigh confidence
US 10,259,810N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-Carboxamides AND METHOD OF USE
conveyed to Galapagos N.V.
In force
 · High confidence
In forceHigh confidence
US 10,829,473Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd.
In force
 · High confidence
In forceHigh confidence
US 10,844,041Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd.
In force
 · High confidence
In forceHigh confidence
US 10,844,042Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd.
In force
 · High confidence
In forceHigh confidence
US 10,981,890Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd.
In force
 · High confidence
In forceHigh confidence
US 10,988,454Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd.
In force
 · High confidence
In forceHigh confidence
US 11,564,923Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
conveyed to Galapagos N.V. - now held by Lakefront Biotherapeutics
In force
 · High confidence
In forceHigh confidence
10 of 44 records shown.
Pro members see all 44.
Pro members: see all 44 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited